TailorMed

Overview

TailorMed is a Medication Success Platform for hospitals, pharmacies, and pharma patient-support programs, matching patients to 6,000+ copay, foundation, free-drug, and government assistance resources and automating enrollment via Express Enroll. Current company materials report 75M+ patients, 5K+ providers, 945+ hospitals, 4,700+ clinics, 3K+ pharmacies, 100+ integrated pharma programs, 335M+ prescriptions processed, and $7.4B+ in assistance secured.

TailorMed is not a full hub vendor; it does not run human intake call centers, prior authorization casework, or specialty pharmacy dispensing. It is an access / affordability / adherence layer manufacturers and providers run alongside a hub, used by oncology, infusion, specialty pharmacy, and patient-facing direct enrollment models.

Hub Capability Model

The framework below standardizes how Rx Almanac evaluates hub-services capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, TailorMed is evaluated as an access, affordability, and adherence layer that runs alongside a hub.

Capability	Buyer should compare	TailorMed readout
Therapy initiation and enrollment intake	Digital and human intake, eConsent, missing-information resolution, provider/patient portals, and clean case creation.	Affordability-side. Express Enroll automates manufacturer-program enrollment; Connect adds patient self-service enrollment, education, reminders, and engagement.
Benefits verification and coverage triage	Medical/pharmacy benefit verification, eligibility checks, payer-policy lookup, coverage routing, and speed from referral to actionable case.	Confirm coverage workflow in the RFP. Not a documented core capability; treat as an integration point with the hub or provider system.
Prior authorization, appeals, and reimbursement casework	PA initiation, payer-specific forms, clinical documentation, appeals, denial management, and field reimbursement handoffs.	Out of scope. TailorMed does not run PA casework; pair with a hub or provider workflow vendor.
Affordability, PAP, and copay operations	Copay, free-drug, bridge, foundation, income verification, PAP renewal, and gross-to-net sensitive affordability logic.	Core. Matching engine across 6,000+ assistance resources; direct API integrations with 70+ pharma assistance programs; company reports $7.4B+ assistance secured.
Patient engagement and adherence operations	Omnichannel reminders, clinical education, nursing or training escalation, persistence outreach, and patient-facing support quality.	Engagement model. Connect supports patient self-service, reminders, education, and engagement; clinical adherence stays with the hub or provider.
Fulfillment, specialty pharmacy, and distribution coordination	Routing to SPs, non-commercial dispensing, DTP shipment, sample/replacement product, 3PL, and cold-chain handoffs.	Fulfillment handoff. Free/replacement drug program management; Flatiron OncoEMR integration enables provider-side dispensing workflows.
Program reporting, integrations, and governance	Manufacturer dashboards, KPI reporting, CRM/EHR/API integrations, SLA governance, and operating visibility across vendors.	Core. Pharmacy/EMR workflow integration plus analytics on navigation performance; confirm manufacturer dashboard cadence and KPI mapping.

Buyer Fit

• Include when: Include TailorMed when a manufacturer wants affordability automation embedded inside the hospital/pharmacy workflow rather than as a manual hub queue — especially for oncology brands where Flatiron and community-oncology footprint matter.
• Best-fit buyers: Pharma manufacturers, biotech, health systems, and providers running oncology, biologics, and high-cost specialty programs that depend on copay cards, foundations, and PAP coordination.
• Less ideal fit: Programs that need a full reimbursement-and-PA hub stack, owned specialty pharmacy, or a closed manufacturer-only operating model.
• Commercial fit: Subscription pricing with module mix across Core, Connect, Complete, Amplify, and Alliance; expect data-feed, integration, and expert-service scope to drive contract value.
• Network diligence: Confirm Express Enroll API coverage of your assistance programs, OncoEMR integration depth, manufacturer reporting cadence, patient consent flows, and data rights inside the Medication Success Platform.

Differentiators

• Large medication-access footprint: Company materials report 75M+ patients, 5K+ providers, 945+ hospitals, 4,700+ clinics, 3K+ pharmacies, and 100+ integrated pharma programs.
• Direct API integrations with 70+ pharma assistance programs: Express Enroll automates copay/PAP/foundation enrollment without manual form re-entry.
• Matching engine across 6,000+ assistance resources: Covers copay cards, foundations, free-drug programs, and government assistance; reduces patient and case-manager search burden.
• $7.4B+ in assistance secured: Current company materials also report 335M+ prescriptions processed; treat these as scale signals to validate in contract diligence.
• Five-module platform: Core, Connect, Complete, Amplify, and Alliance separate care-team navigation, patient self-service, expert-team assistance operations, life-sciences activation, and partner expansion.
• Flatiron OncoEMR integration (May 2026): Direct integration into community oncology EMR workflows; meaningful for oncology launch teams targeting Flatiron-network providers.

RFP Questions

• Which manufacturer assistance programs are live in Express Enroll today, and which require new build-out?
• How is patient consent captured and managed across the Affordability Network for hospital, pharmacy, and patient-facing enrollment?
• What manufacturer dashboards and KPIs (enrollment count, time-to-enrollment, $ assistance unlocked, abandonment) are available, and how often are they refreshed?
• How does the Flatiron OncoEMR integration handle handoff between the EMR, the hub, and the dispensing pharmacy?
• Which TailorMed modules - Core, Connect, Complete, Amplify, and Alliance - fit a manufacturer-funded patient-services scope versus a provider-funded scope?
• What data rights does TailorMed retain on patient-level and assistance-program-level data, and how is that data shared with manufacturers?
• How does Connect (virtual copay wallet) interact with manufacturer copay-card vendors and accumulator/maximizer mitigation?

Recent Activity

• 2026-05: Current TailorMed materials positioned the company as a Medication Success Platform with 75M+ patients, 5K+ providers, 945+ hospitals, 4,700+ clinics, 3K+ pharmacies, 100+ integrated pharma programs, 335M+ prescriptions processed, and $7.4B+ assistance secured.
• 2026-05: Flatiron Vendor Network integration — direct integration into OncoEMR for community oncology providers.
• 2026-04 (AXS26 Summit): Medication Success Platform formal launch — 5-module structure (Core / Amplify / Alliance enterprise + Connect patient-facing wallet).
• 2025-10: TailorMed Affordability Network self-enrollment digital experience launched for patient-direct access to copay assistance, foundation grants, and government programs.
• 2025-06: KabaFusion long-term contract renewal — national home-infusion provider, focused on lower out-of-pocket for complex IV treatments.
• 2024-10: Secured $40M to expand the Affordability Network into an end-to-end platform.
• 2021: Acquired Vivor (financial-assistance technology platform); added Portland, OR West Coast office.